Back |
home / stock / prog / prog message board
Subject | By | Source | When |
---|---|---|---|
I do believe today is the last day | foti1kenobi | investorshub | 12/29/2021 5:41:42 PM |
A company with a patent on taking injectable | foti1kenobi | investorshub | 12/29/2021 5:38:35 PM |
Yeah from $5 down to 1.8 in only | Torez | investorshub | 12/29/2021 5:01:19 PM |
Just panic selling. The price will rise gradually. | ttottip | investorshub | 12/29/2021 3:23:28 PM |
$1 will come fast now lol . | Torez | investorshub | 12/29/2021 2:42:20 PM |
Lol yup since $3 | Torez | investorshub | 12/29/2021 1:47:28 PM |
Good morning all ! Waiting for the short squeeze. | ttottip | investorshub | 12/29/2021 1:14:45 PM |
Welcome to 1s | Torez | investorshub | 12/29/2021 11:39:02 AM |
No you said - tomorrow very green | Torez | investorshub | 12/28/2021 9:07:16 PM |
prog on sale now. buy, buy, buy. | Stockman1010101 | investorshub | 12/28/2021 9:01:53 PM |
it could. I do not look at it | Stockman1010101 | investorshub | 12/28/2021 8:41:30 PM |
Dont get too cocky buddy - only 3%, | Torez | investorshub | 12/28/2021 4:29:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the first quarter ended March 31, 2024. The company’s ...
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present clinical data on device function of the NaviCap™ Targeted Oral Delivery Platform at Digestive Disease...
Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024 SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, ...